Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Epidemiology Biomarkers and Prevention is Scopus-indexed (Q2, CiteScore 5.4), WoS SCIE. Published by American Association for Cancer Research Inc..
Checked against the index lists dated .
ISSN 1055-9965Verify ISSN ↗1538-7755Verify ISSN ↗
Publisher: American Association for Cancer Research Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Epidemiology | 46 / 173 | 73rd | Q2 |
| Oncology | 138 / 428 | 67th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1991–present (also 1986, 1983), best quartile Q2, CiteScore 5.4.
Cancer Epidemiology Biomarkers and Prevention is Q2 in Epidemiology (rank 46 of 173) and Q2 in Oncology (rank 138 of 428), by CiteScore 2025.
Cancer Epidemiology Biomarkers and Prevention is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.4, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.426, quartile Q1, with an H-index of 223.
Cancer Epidemiology Biomarkers and Prevention is published by American Association for Cancer Research Inc. Its print ISSN is 1055-9965 and its online ISSN is 1538-7755.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cancer Epidemiology Biomarkers and Prevention has an h-index of 212 and a 2-year mean of 0.9 citations per paper (OpenAlex). Its Scopus CiteScore is 5.4, quartile Q2. On 2-year citations it ranks #115 of 171 Scopus journals in Epidemiology.
Cancer Epidemiology Biomarkers and Prevention published 864 papers in 2025; its busiest recent year was 2020 with 1,682. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from United States (60.5%), Australia (4.7%) and China (4.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.